Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation

被引:58
作者
Bellandi, F [1 ]
Simonetti, I [1 ]
Leoncini, M [1 ]
Frascarelli, F [1 ]
Giovannini, T [1 ]
Maioli, M [1 ]
Dabizzi, RP [1 ]
机构
[1] Misericordia & Dolce Hosp, Div Cardiol, Prato, Italy
关键词
D O I
10.1016/S0002-9149(01)01806-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was performed to evaluate, using a randomized double-blind, placebo-controlled protocol, the longterm efficacy and safety of propafenone and sotalol in maintaining sinus rhythm after conversion of recurrent symptomatic atrial fibrillation (AF). The maintenance of sinus rhythm in patients with recurrent AF has several potential benefits, the most important being a reduced risk of thromboembolic events. Three hundred patients with recurrent AF (greater than or equal to4 episodes in the last year) and AF at enrollment lasting <48 hours were randomized to receive either propafenone (mean daily dose 13 +/- 1.5 mg/kg; 102 patients), sotalol (mean daily dose 3 +/- 0.4 mg/kg; 106 patients), or placebo (92 patients). After 1-year follow-up, Kaplan-Meier estimates of the proportion of patients remaining in sinus rhythm were comparable between propafenone (63%) and sotalol (73%) and superior to placebo (35%; p = 0.001 vs both drugs). Symptomatic recurrences occurred later with propafenone and sotalol than with placebo. Nine patients (9%) in the propafenone group, 11 (10%) in the sotalol group, and 3 (3%) in the placebo group discontinued therapy due to adverse effects. Malignant nonfatal arrhythmias due to proarrhythmic effects were documented with sotalol only, and occurred <72 hours from the beginning of therapy in 4 patients (4%). During recurrences, the ventricular rate was significantly reduced in patients taking propafenone and sotalol (p = 0.001 for both drugs vs placebo). The likelihood of remaining in sinus rhythm during follow-up was higher in younger patients with smaller left atria[ size and without concomitant heart disease. In patients with recurrent symptomatic AF, propafenone and sotalol are not significantly different from each other and are superior to placebo in maintaining sinus rhythm at 1 year. Recurrences occur later and tend to be less symptomatic with propafenone and sotalol compared with placebo. (C) 2001 by Excerpta Medica, Inc.
引用
收藏
页码:640 / 645
页数:6
相关论文
共 29 条
[1]   Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol [J].
Alt, E ;
Ammer, R ;
Lehmann, G ;
Putter, K ;
Ayers, GM ;
Pasquantonio, J ;
Schomig, A .
AMERICAN HEART JOURNAL, 1997, 134 (03) :419-425
[2]   THERAPY OF REFRACTORY SYMPTOMATIC ATRIAL-FIBRILLATION AND ATRIAL-FLUTTER - A STAGED CARE APPROACH WITH NEW ANTIARRHYTHMIC DRUGS [J].
ANTMAN, EM ;
BEAMER, AD ;
CANTILLON, C ;
MCGOWAN, N ;
FRIEDMAN, PL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (03) :698-707
[3]  
Bazett HC, 1920, HEART-J STUD CIRC, V7, P353
[4]   Regional attitudes of generalists, specialists, and subspecialists about management of atrial fibrillation [J].
Brodsky, MA ;
Chun, JG ;
Podrid, PJ ;
Douban, S ;
Allen, BJ ;
Cygan, R .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (22) :2553-2562
[5]   ATRIAL-FIBRILLATION - RISK MARKER FOR STROKE [J].
CHESEBRO, JH ;
FUSTER, V ;
HALPERIN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (22) :1557-1558
[6]   Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications [J].
Chung, MK ;
Schweikert, RA ;
Wilkoff, BL ;
Niebauer, MJ ;
Pinski, SL ;
Trohman, RG ;
Kidwell, GA ;
Jaeger, FJ ;
Morant, VA ;
Miller, DP ;
Tchou, PJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (01) :169-176
[7]   EFFICACY AND SAFETY OF QUINIDINE THERAPY FOR MAINTENANCE OF SINUS RHYTHM AFTER CARDIOVERSION - A METAANALYSIS OF RANDOMIZED CONTROL TRIALS [J].
COPLEN, SE ;
ANTMAN, EM ;
BERLIN, JA ;
HEWITT, P ;
CHALMERS, TC .
CIRCULATION, 1990, 82 (04) :1106-1116
[8]   Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: A randomized, double-blind study [J].
Crijns, HJGM ;
Gosselink, ATM ;
Lie, KI .
CARDIOVASCULAR DRUGS AND THERAPY, 1996, 10 (02) :145-152
[9]  
de Paola AAV, 1999, AM J CARDIOL, V84, P1033
[10]   RESPONSE OF ATRIAL-FIBRILLATION TO THERAPY - ROLE OF ETIOLOGY AND LEFT ATRIAL DIAMETER [J].
EWY, GA ;
ULFERS, L ;
HAGER, WD ;
ROSENFELD, AR ;
ROESKE, WR ;
GOLDMAN, S .
JOURNAL OF ELECTROCARDIOLOGY, 1980, 13 (02) :119-123